Obshchee rukovodstvo Mezhdunarodnoy Diabeticheskoy Federatsii po sakharnomu diabetu 2 tipa (kratkoe izlozhenie)
https://doi.org/10.14341/2072-0351-5868
Abstract
Настоящее Руководство представляется значительным достижением в обобщении международного опыта, в области сахарного диабета 2 типа и, несомненно, долж- но быть известно широкому кругу врачей ? не только эндокринологам, но и терапевтам и всем специалистам, работающим с осложнениями сахарного диабета.
About the Author
Irina Vladimirovna Gur'eva
Федеральное бюро медико-социальной экспертизы, Москва; Российская медицинская академия последипломного образования, Москва
References
1. Business Briefing. European Endocrine review 2006. A report by W.J.M. Wientiens. P.14.
2. Business Briefing. European Endocrine review 2006. Prevention through Awareness - Raising Global Awareness of Diabetes and its Complications. P.Lefebre and Anne Pierson. P.24-26. www.touchbriefings.com
3. Global Guidelines for Type 2 Diabetes. International Diabetes Federation,2005:1-79.
4. World Health Organization. Definition. Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of WHO Consultation. Part 1:Diagnosos and Classification of Diabetes Mellitus. Geneva:WHO Department of noncommunicable Disease Surveillance, 1999:1-59. http:/www.who.int
5. American Diabetes Association: Position Statement. Tests of glycemia in diabetes.Diabetes Care,2004.27(Suppl.1.) S.91-93.
6. Mclntosh A., Hattchinson A., Home PD, et al. Clinical guidlinesand evidence review for type 2 diabetes:management of blood glucose. 2001.http://www.nice.org.uk/pdf/NICE_full_blood_glucose.pdf
7. European Diabetes Policy Group 1999. A desktop guide to type 2 diabetes mellitus. Diab.Med1999;16:716- 30.http://www.staff.ncl.ac.uk/Philip.home/guidelines
8. Gray A.,Raikou M., Fenn P., et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomized controlled trial (UKPDS)41.BMG 2000;320:1373-78.
9. Canadian Diabetes Association Clinical Practice Guideline Expert committee. Canadian Diabetes association Clinical Practice Guidelines for prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 2003;27(Suppl2):S37-42.htt://www.diabetes.ca
10. Institute for Clinical Systems Improvement (Bloomington, MIN, USA). Management of Type 2 Diabetes Mellitus,2004.http://www.icsi.org/knowlege
11. Nesto R.W.,Bell D., Bonow R.O. et al.Tiozolidindione use, fluid retention, and congestive heart failure. A concensus statement from the American heart Associationand American Diabetes association. Diabetes Care 2004;27:256-63.
Review
For citations:
Gur'eva I.V. Obshchee rukovodstvo Mezhdunarodnoy Diabeticheskoy Federatsii po sakharnomu diabetu 2 tipa (kratkoe izlozhenie). Diabetes mellitus. 2007;10(4):54-56. (In Russ.) https://doi.org/10.14341/2072-0351-5868
Views:
703
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
